Table 2 Strength of muscle groups of 4 HIBM patients at baseline and after IVIG treatment.
From: Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study
| Â | Hip Flexion | Ankle Dorsiflexion | Elbow | Wrist | Hand | |||
|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Flexion | Extension | Flexion | Extension | Grip | Pinch |
Baseline a,b | 3.21 ± 0.84 | 3.50 ± 2.15 | 4.71 ± 1.42 | 3.36 ± 1.09 | 5.24 ± 0.86 | 4.55 ± 0.46 | 7.43 ± 1.63 | 1.02 ± 0.22 |
Post-Load b | 3.93 ± 0.74 (+22%) | 2.53 ± 1.55 (-28%) | 5.56 ± 1.60 (+18%) | 3.30 + 0.98 (-2%) | 5.81 ± 1.07 (+11%) | 5.15 ± 0.58 (+13%) | 7.85 ± 1.65 (+6%) | 1.03 ± 0.16 (+1%) |
End of study b | 3.63 ± 0.62 (+13%) | 4.28 ± 2.87 (+22%) | 5.45 ± 1.55 (+16%) | 3.36 ± 1.03 (0%) | 6.25 ± 1.15 (+19%) | 5.78 ± 0.93 (+27%) | 7.83 ± 1.59 (+5%) | 1.37 ± 0.25 (+35%) |